These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12966791)
1. [Conflicting evaluations of the PROGRESS Study]. Hausberg M; Kosch M; Rahn KH Internist (Berl); 2003 May; 44(5):631-2. PubMed ID: 12966791 [No Abstract] [Full Text] [Related]
2. The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study. Psaty BM; Weiss NS; Furberg CD Am J Hypertens; 2002 May; 15(5):472-4. PubMed ID: 12022252 [No Abstract] [Full Text] [Related]
3. The PROGRESS trial three years later: time for a balanced report of effectiveness. Wennberg R; Zimmermann C BMJ; 2004 Oct; 329(7472):968-70. PubMed ID: 15499116 [TBL] [Abstract][Full Text] [Related]
4. Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide. Padma MV; Kaul S Neurol India; 2007; 55(2):141-4. PubMed ID: 17558118 [TBL] [Abstract][Full Text] [Related]
5. The PROGRESS trial three years later: time for more action, less distraction. Macmahon S; Neal B; Rodgers A; Chalmers J BMJ; 2004 Oct; 329(7472):970-1. PubMed ID: 15499117 [No Abstract] [Full Text] [Related]
6. [Clinical efficacy of noliprel in the treatment of hypertension. Main results of ETALON]. Oganov RG; Nebieridze DV Kardiologiia; 2004; 44(3):66-9. PubMed ID: 15489830 [No Abstract] [Full Text] [Related]
7. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients? Schiffrin EL Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782 [No Abstract] [Full Text] [Related]
8. Clinical implications of PROGRESS: questions and answers. Chalmers J; Adams HP; Donnan GA; Fox K; MacMahon S; Mancia G; Tzourio C J Hypertens Suppl; 2003 Jun; 21(5):S21-4. PubMed ID: 12953852 [No Abstract] [Full Text] [Related]
9. [Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial]. Matsumoto M Nihon Rinsho; 2004 Mar; 62 Suppl 3():605-11. PubMed ID: 15179938 [No Abstract] [Full Text] [Related]
11. Invited commentary. Stroke preventive treatment using perindopril and indapamide in the context of Indian primary care. Wennberg RA; Zimmermann C Neurol India; 2007; 55(2):101-2. PubMed ID: 17558107 [No Abstract] [Full Text] [Related]
12. You should treat patients over the age of 80 who have hypertension. Lundberg GD Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637 [No Abstract] [Full Text] [Related]
13. Controversy in treating the oldest old with hypertension: is the hypertension in the very elderly trial the final answer? Abramov D; Cheng H J Am Geriatr Soc; 2009 Mar; 57(3):570-1. PubMed ID: 19278408 [No Abstract] [Full Text] [Related]
14. [Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke]. Masson C Presse Med; 2001 Nov; 30(35):1716-7. PubMed ID: 11775593 [No Abstract] [Full Text] [Related]